The incidence of inflammatory bowel disease (IBD) is rising in racial and ethnic underserved population continue to drive disparities in outcomes. Individualized treatment strategies are needed, including shared decision-making and a multidisciplinary team approach, to work toward providing equitable care for patients with IBD.
In this CME Outfitters BriefCase, Drs. Peek and Quezada will guide learners through a patient case scenario reflective of the impact of biases, disparities, and health inequities that exist in racial and ethnic underserved patients with IBD. This program will provide actionable strategies, empowering attendees to recognize social determinants of health and implement changes in practice to improve IBD treatment.
At the end of this CME/CE activity, participants should be able to:
Supported by an educational grant from Johnson & Johnson.
Physicians, physician associates (PAs), nurse practitioners (NPs), nurses, pharmacists, dieticians specializing in gastroenterology, surgery, primary care, or internal medicine.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Peek reports the following financial relationships: Consultant: Pfizer Inc.
Dr. Quezada reports the following financial relationships: Advisory Board Janssen Pharmaceuticals, Inc. People of Color Advisory Board
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at (877) CME-PROS or (877) 263-7767.